AstraZeneca PLC (AZN) operating KPIs
AZNNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Score 12/30
$163.95−1.46 (-0.88%)
Close on Oct 19, 2026Market cap $255.76BP/E 25.1Yield 1.91%
AstraZeneca total provisions (current + non-current) ($M) ($M)
Form 20-F Note 21 — Provisions Rollforward by Category
Latest, FY2025
1,604
Period ended Dec 31, 2025
Change on a year earlier
-26.8%
2,190 in FY2024
History
7 years
Since FY2019
Sources
3
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Total provisions (current + non-current) ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 1,604 | -26.8% | Form 20-F FY2025 Annual Report ↗ |
| FY2024 | Dec 31, 2024 | 2,190 | +1.6% | Form 20-F FY2025 Annual Report ↗ |
| FY2023 | Dec 31, 2023 | 2,155 | +33.2% | Form 20-F FY2025 Annual Report ↗ |
| FY2022 | Dec 31, 2022 | 1,618 | -6.1% | Form 20-F FY2024 Annual Report ↗ |
| FY2021 | Dec 31, 2021 | 1,724 | +10.5% | Form 20-F FY2024 Annual Report ↗ |
| FY2020 | Dec 31, 2020 | 1,560 | -0.3% | Form 20-F FY2023 Annual Report ↗ |
| FY2019 | Dec 31, 2019 | 1,564 | – | Form 20-F FY2023 Annual Report ↗ |
Breakdown
What makes up total provisions (current + non-current) ($m)
- Legal & product liability provisions ($M)376 · FY2025
- Severance & restructuring provisions ($M)197 · FY2025
- Environmental remediation provisions ($M)107 · FY2025
- Employee benefit provisions ($M)190 · FY2025
- Other provisions ($M)734 · FY2025
- Total provisions cash utilised / settled during year ($M)1,249 · FY2025
- Unused provisions reversed during year ($M)157 · FY2025
Cite this data
StockData. (2026). AstraZeneca Total provisions (current + non-current) ($M) ($M), annual FY2019–FY2025 [Data set]. Compiled from AstraZeneca SEC filings and investor materials. https://stockdatahq.com/stocks/azn/kpis/prov_total
See every metric in the AstraZeneca KPI table. Data updated Oct 28, 2026.